Clinical Trial Update: HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on HLA-identical sibling donor bone marrow transplantation with reduced-intensity conditioning for individuals with severe sickle …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Guard Health Affairs | Conditions: Sickle Cell Disease | Phase 2 | Status: UNKNOWN